, Fifth Edition (DSM-5)—a reference textual content industry experts use to diagnose compound use disorders together with other psychiatric disorders—involves diagnoses of phencyclidine (PCP) use disorder and “other hallucinogen use disorder” but does not include compound use disorder diagnoses relevant to other distinct copyright and disso